Hyperkalaemia with cyclooxygenase-2 inhibition and hypoaldosteronism

Internal Medicine Journal

Volumn 35, Issue 9, 2005, Pages 572-573

  Lam, Q ^a   Schneider, H G ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CATION EXCHANGE RESIN; CELECOXIB; CORTICOTROPIN; CYCLOOXYGENASE 2; FLUDROCORTISONE; HYDROCORTISONE; LOW MOLECULAR WEIGHT HEPARIN; NAPROXEN; POTASSIUM; RENIN; SODIUM;

ADULT; ALDOSTERONE BLOOD LEVEL; ANAMNESIS; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; ENZYME INHIBITION; HOSPITAL ADMISSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERKALEMIA; HYPOALDOSTERONISM; MALE; PLASMA RENIN ACTIVITY; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; PROPHYLAXIS; SODIUM URINE LEVEL; TREATMENT OUTCOME;

ADULT; ALDOSTERONE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FOLLOW-UP STUDIES; HUMANS; HYPERKALEMIA; HYPOALDOSTERONISM; MALE; NAPROXEN;

EID: 24744460902     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00900.x     Document Type: Article

References (4)

1. Davenport MW, Zipser R. Association of hypotension with hyperreninemic hypoaldosteronism in the critically Ill patient. Arch Intern Med 1983; 143: 735-7.
2. Perazella MA. Drug-induced hyperkalemia old culprits new offenders. Am J Med 2000; 109: 307-14.
3. FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001; 345: 433-42.
4. Qi Z, Hao C-M, Langenbach RI, Breyer RM, Redha R, Morrow JD et al. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 2002; 110: 61-9. 573-574